Periscope Capital’s Cano Health, Inc. CANO Stock Holding History

Periscope Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,215	Closed	-$4.39M	–	395
2020 Q3	$4.39M	Buy	+4,215	New	+$4.41M	0.3%	125

Other funds holding CANO

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Periscope Capital's CANO Position: Q4 2020 in Review

Periscope Capital sold out of Cano Health, Inc. (CANO) in Q4 2020, closing a stake of 4,215 shares — an estimated $4.39M sold.

Periscope Capital first reported a position in CANO in Q3 2020 and held it in 1 quarter. The position peaked at $4.39M in Q3 2020. 81 funds tracked by Wall St. Rank hold CANO as of Q4 2020.

Periscope Capital reported no remaining Cano Health, Inc. position as of Q4 2020 after selling out during the quarter.
Periscope Capital sold 4,215 Cano Health, Inc. shares in Q4 2020, an estimated $4.39M.
Periscope Capital first reported a position in Cano Health, Inc. in Q3 2020 and held it in 1 quarter.
Periscope Capital's Cano Health, Inc. position peaked at $4.39M in Q3 2020.
81 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2020.

Based on Periscope Capital's 13F filing for Q4 2020, filed 10 Feb 2021.